Summary
Overview
Work History
Education
Skills
Languages
Patents
Timeline
Generic

ROBERT VAN GORP

CINCINNATI METRO AREA,OHIO

Summary

Business development and sales leader with over 20 years of experience in driving operational success and revenue growth. Expertise in client acquisition, contract negotiation, and team leadership. Proven track record in surpassing sales targets and revenue objectives through strategic initiatives.

Overview

36
36
years of professional experience

Work History

Sales Manager

Cook Myosite, Inc.
Pittsburgh, Pennsylvania
11.2024 - Current
  • Led sales team to execute strategic initiatives and drive revenue growth.
  • Collaborated with marketing to create targeted campaigns that increased customer engagement.
  • Analyzed market trends to identify opportunities for expanding product offerings.
  • Established strong relationships with key clients to ensure customer satisfaction and loyalty.
  • Established relationships with key clients, while maintaining existing customer base.
  • Established new accounts and serviced existing accounts maintaining professional relationships.
  • www.cookmyosite.com

VP, Strategic Sourcing

IHP Therapeutics, Inc.
San Carlos, USA
01.2020 - Current
  • Founding member, co-innovator and recruited top level team and advisors.
  • PIND CMC team member, submitted under CTAP, Type B meeting with FDA.
  • Successfully identified, negotiated supply and imported NCE API into U.S.
  • Managed qualification and tech. transfers from API, CTO and CMO for IND input.
  • IND team member, granted FDA ‘Study May Proceed’ within 30 days of submission.
  • IHP is clinical-stage start-up virtual Biotech company developing antiviral agents with potential activity against COVID19 and other infectious pathogens. (http://www.ihptherapeutics.com)

Business Development Manager

DCW
New York, New York
05.2021 - 02.2025
  • Orchestrated and promoted new business with large pharmaceutical partners to diversify customer base.
  • Created CMC team to enhance cGMP through innovative supply chain strategies and regulatory tactics.
  • Authored validation protocols to address process non-compliance and reduce out-of-specification rates.

Business Development and Sales Consultant

Ibex Pharmaceuticals, Inc.
Montreal, Canada
09.2018 - 09.2019
  • Generated revenues increase of approximately 20% for a six-month period.
  • Rekindled relationship with several dormant accounts translating into new sales.
  • IBEX is a Canadian manufacturer of heparin related recombinant enzymes for diagnostic and device uses. (http://www.ibex.ca)

VP Operations & General Manager

Celsus Laboratories, Inc.
Cincinnati, USA
09.1989 - 07.2018
  • Began as a plant operator working full time while attending college; responsibilities grew.
  • Held the title of VP of Operations and General Manager for a tenure of more than 10 years.
  • 2014 to 2017- Selected to lead and increase short term profit margins, enhance sales with coordinated strategic plan, promote signing of letter of intent and post-acquisition transition to new ownership with control and successful retention of key employees and businesses. All objectives were achieved as of June of 2017.
  • Primary, most responsible person in facility & management contact for US FDA district office & audit lead for unannounced on-site facility inspections in 2016, 2014, 2012, 2011, 2009. All inspections resulted with excellent results (Redacted EIR summaries available upon request).
  • 2008 to 2014 - Managed multiple priorities in fast-paced environment and was instrumental in company’s response to industry-wide ‘heparin crisis’. Overcame obstacles with innovative/value-added supply chain strategies, process and quality adjustments and regulatory tactics. Initiatives increased revenues sequentially by 10% for 4 straight years.
  • CELSUS was a manufacturer of heparin derived pharmaceutical ingredients and medical device components found in various drug products and medical devices such as stents, oxygenators, heart valves, venous and arterial catheters and blood collection tubes. Acquired in 2017 by SFD. (http://www.smithfieldbioscience.com)

Education

Masters of Business Administration -

UNIVERSITY PHOENIX ONLINE
Phoenix, AZ, USA
05.2006

Bachelor of Arts - International Studies

MIAMI UNIVERSITY
Oxford, OH, USA
05.1991

Skills

  • Sales strategy
  • Customer relationship management
  • Market analysis
  • Client retention strategies
  • Revenue forecasting
  • Business development
  • Regulatory compliance
  • Team leadership
  • Negotiation skills

Languages

  • English, Native (US)
  • French, Fluent (Swiss)

Patents

Partially Desulfated Heparin for Treating Coronaviral Infections, PCT/US2021/037265

Timeline

Sales Manager

Cook Myosite, Inc.
11.2024 - Current

Business Development Manager

DCW
05.2021 - 02.2025

VP, Strategic Sourcing

IHP Therapeutics, Inc.
01.2020 - Current

Business Development and Sales Consultant

Ibex Pharmaceuticals, Inc.
09.2018 - 09.2019

VP Operations & General Manager

Celsus Laboratories, Inc.
09.1989 - 07.2018

Masters of Business Administration -

UNIVERSITY PHOENIX ONLINE

Bachelor of Arts - International Studies

MIAMI UNIVERSITY
ROBERT VAN GORP